FDA reviews psychiatric side effects of Chantix

Friday, April 25, 2014 - 17:00 in Health & Medicine

WASHINGTON (AP) -- The Food and Drug Administration announced Friday it will hold a public meeting in October to review the risks of psychiatric and behavioral side effects with Pfizer's anti-smoking drug Chantix....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net